Stockreport

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights

PMV Pharmaceuticals, Inc.  (PMVP) 
PDF Enrollment on track in Phase 2 pivotal portion of PYNNACLE clinical trial evaluating rezatapopt as monotherapy in patients with TP53 Y220C and KRAS wild-type advanced so [Read more]